Mineralocorticoid Receptor Blocker Prevents Mineralocorticoid Receptor-Mediated Inflammation by Modulating Transcriptional Activity of Mineralocorticoid Receptor-p65-Signal Transducer and Activator of Transcription 3 Complex.
Naoto KuyamaSatoshi ArakiKoichi KaikitaNobuhiro NakanishiNaoya NakashimaShinsuke HanataniYuichiro ArimaMasahiro YamamotoTaishi NakamuraEiichiro YamamotoKenichi MatsushitaKunihiko MatsuiKenichi TsujitaPublished in: Journal of the American Heart Association (2024)
Esaxerenone ameliorated postinfarct remodeling in experimental MI through its anti-inflammatory properties exerted by modulating the transcriptional activity of the MR-p65-STAT3 complex. These results suggest that the MR-p65-STAT3 complex can be a novel therapeutic target for treating MI.